A growing body of evidence have reported that elevated SREBP1 at both the RNA or protein levels is not only associated with malignant transformation, cancer progression, and metastasis, in vitro and in vivo, but also with a poor survival outcome in many solid tumors [53]. The gene discussed is SREBF1; the disease is cancer.